INTRODUCTION
Aplastic anemia (AA) is a rare bone marrow failure (BMF) disease characterized by peripheral pancytopenia and hypoplastic bone marrow (BM). 1 Most cases of acquired AA are idiopathic occurring both in children and adults, with roughly equal frequency in both genders. 1, 2 Studies of AA patients and animal models of BMF suggest acquired AA is an immune-mediated disease. 3, 4 Aberrant responses mediated by T helper type-1 (Th1), T helper type-17 (Th17), and cytotoxic CD8 + T cells, together with impaired function of regulatory T (Treg) cells, [5] [6] [7] [8] [9] [10] culminate in bone marrow destruction. Although the pathophysiology of AA is well-defined, the molecular mechanisms responsible for T cell-infiltration into the BM during AA progression are poorly understood.
Small populations of mature CD4 + and CD8 + T cells reside in the BM. It is a priming site for antigen-specific T cells, [11] [12] [13] as well as a homing site for memory T cells. [14] [15] [16] Physiologically,
T cells migrate to the BM in response to chemokines, such as stromal-cell derived factor-1α (SDF-1α) which is highly-expressed by BM stromal cells. 17, 18 SDF-1α, also known as CXCL12, is the natural ligand for the chemokine receptor, CXCR4. 19 SDF-1α-CXCR4 interactions initiate multiple signaling pathways that augment T cell co-stimulation, proliferation, cytokine production, migration, and survival. [20] [21] [22] [23] [24] [25] In T cells, activation through the T cell receptor (TCR), polyclonal stimulation, SDF-1α interaction, and IFNγ are stimuli that down-regulate CXCR4, while signaling through IL-2, IL-4, IL-7, and IL-15 upregulates its expression.
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The nuclear factor-kappa B (NF-κB) family of transcription factors consists of five subunits, RelA (p65), RelB, c-Rel, NF-κB1 (p50), and NF-κB2 (p52), that function as homo-or heterodimers. NF-κB signaling plays a central role in T cell activation, proliferation, differentiation, and survival.
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For personal use only. on October 31, 2017. by guest www.bloodjournal.org From Dysregulated CXCR4 and NF-κB signaling pathways contribute to disease pathology in multiple immune-mediated diseases including multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, and type 1 diabetes. [33] [34] [35] [36] [37] [38] [39] [40] [41] Both signaling pathways have also been associated with hematopoietic and non-hematopoietic malignancies. [42] [43] [44] Moreover, NF-κB-mediated regulation of CXCR4 expression and function in breast, pancreatic, gastric, prostatic, and ovarian cancers is well documented. [45] [46] [47] [48] [49] [50] [51] However, the contribution of CXCR4 and NF-κB signaling pathways to the pathology of acquired AA has not previously been explored.
Through pharmacological and genetic approaches, we demonstrate that CXCR4 mediates migration of pathogenic T cells to the BM in an established mouse model of immune-mediated AA. 5 We further show that CXCR4 is differentially regulated by NF-κB in naïve and BMinfiltrating CD8 + T cells. Inhibiting NF-κB signaling in AA mice decreased CXCR4 expression on BM-infiltrating CD8 + T cells, significantly reduced BM-infiltration of T cells, and strongly attenuated disease symptoms. Finally, we show that therapeutic inhibition of NF-κB signaling significantly prolonged the survival of AA mice.
MATERIALS and METHODS

Animals
Animal studies were conducted in compliance with the Institutional Animal Care and Use
Committee of the University of Massachusetts Amherst. F1 progeny were obtained by crossing BALB/c females with C57BL/6 males. Conditional Cxcr4 knockout (CXCR4 -/-) mice were generated on a C57BL/6J background by crossing Cxcr4 fl/fl mice (B6.129P2-Cxcr4 tm2Yzo /J) to Mice were harvested on day +17. For survival studies, mice were humanely euthanized when they could no longer eat or drink. BM cells were flushed from tibias and femurs of legs using 5% FBS/PBS. Splenocytes were passed through a 40μM filter, RBCs lysed with ACK buffer, and
WBCs enumerated using trypan blue exclusion. Circulating WBC and RBC were counted using a HemaTrue Hematology Analyzer (Heska). For qRT-PCR studies, T cells were isolated from spleens or bone marrow of AA mice using anti-mouse CD4 and CD8 magnetic particles (BD Biosciences) and separated using the BD IMag system.
In vivo administration of CXCR4 and NF-κB inhibitors
For CXCR4 inhibition studies, mice were treated on day +7 post-disease induction with AMD3100 (5mg/kg/day; Calbiochem) administered via i.p. injection continuing until day +16. 
Histology
On day +17 post-disease induction, sterna were harvested, fixed overnight in 10% neutral buffered formalin (VWR), decalcified for 48 hours in Cal-Rite (Richard Allen Scientific), then preserved in 70% ethanol at 4°C until processed, paraffin-embedded, sectioned, and stained with hematoxylin and eosin.
Mixed lymphocyte reaction and chemotaxis assay
To generate BM-derived dendritic cells (BMDC), BM cells from F1 progeny were cultured (10 6 cells/ml) in RPMI 1640 medium supplemented with 10% FBS (Gibco), 2mM L-glutamine, 100U/ml penicillin, 100μg/ml streptomycin and 20ng/ml GM-CFS (R&D Systems), and incubated at 37°C with 5% CO 2 . On days 2 and 4 post-culture, half the media was removed and replaced with fresh supplemented media. On day 6 post-culture, non-adherent cells were harvested and cultured in fresh supplemented media for 2 additional days. For MLR, BMDC were co-cultured with bulk splenocytes (1:10 from age-and gender-matched C57BL/6 mice) in a 1:1 mixture of RPMI 1640 and DMEM medium supplemented with 10% FBS, 2mM Lglutamine, 1mM sodium pyruvate, 100U/ml penicillin, and 100μg/ml streptomycin in 96-well round-bottom plates and incubated at 37°C with 7% CO 2 for 12 days. To inhibit NF-κB, 1μM
Bay11 or equivalent volume of DMSO was added at time of plating. From days 6 to 12 postculture, non-adherent cells were harvested every other day and CXCR4 expression on CD4 + and CD8 + T cells was analyzed by flow cytometry. On day 8 post-culture, non-adherent cells were harvested to evaluate their chemotactic response to SDF-1α. Chemotaxis assays were performed in 24-well plate transwell inserts (5μm polycarbonate membrane, 6.5mm insert; Corning Costar). 
Flow cytometry
Single-cell suspensions from spleens and BM were surface-stained with PerCP-conjugated anti-CD4 (RM4-5; BD Pharmingen), PE-Cy7-conjugated anti-CD8a (53-6.7; eBioscience), APC- Samples were acquired on an LSRII flow cytometer and analyzed using FACSDiva acquisition software (BectonDickinson). Analyses of FACS data were performed using FACSDiva or FlowJo (Tree Star) software.
Cytometric bead array
Plasma cytokine levels were determined using Th1/Th2 cytometric bead array kits (BD Bioscience) following manufacturer's protocol. Data were acquired on an LSRII flow cytometer and analyzed using FCAP array software (BD Bioscience). 
RNA isolation and quantitative real-time PCR
Total RNA was extracted using RNAqueous kits (Ambion) according to the manufacturer's protocol. RNA (1μg) was reverse transcribed to cDNA using dNTPs (Roche), M-MuLV reverse transcriptase reaction buffer (New England Biolabs, Inc.), oligo-(dT) [12] [13] [14] [15] [16] [17] [18] 
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed as described. 5 Briefly, cells were crosslinked with 1% formaldehyde, lysed in SDS lysis buffer (1% SDS, 10 mM EDTA, and 50mM
Tris, pH8. 
Statistical analysis
Results are the mean ± SEM. Statistical analyses were performed using GraphPad Prism 5 (GraphPad Software). P values were calculated using an unpaired two-tailed Student's t test, one-or two-way ANOVA with post-tests as indicated. Survival curves were generated using the Kaplan-Meier method and survival differences were determined with a Mantel-Cox log-rank test. P values of ≤ 0.05 were considered statistically significant.
RESULTS
CXCR4 is highly expressed on T cells of AA mice
T cells utilize CXCR4-SDF-1α interactions to traffic to the bone marrow during homeostatic processes, 17, 18 but how pathogenic T cells are targeted to the bone marrow during AA is not well understood. Here we sought to determine whether CXCR4 contributes to the pathogenesis of immune-mediated AA. Using a well-characterized, lymphocyte transfer mouse model of AA, 5 we first assessed transcript and protein expression of CXCR4. Seventeen days post-disease induction, Cxcr4 transcripts in T cells from spleens and BM were expressed at similar levels both in AA mice and irradiation controls (Fig. 1A) ; however, for many genes, there is only modest correlation between mRNA levels and their translated proteins. 52 When we further assessed 1 0
protein levels, we found surface expression of CXCR4 was significantly higher on T cells isolated from spleens and BM of AA mice (Fig. 1B, C ), as were percentages of CXCR4 + T cells ( Fig. 1D ), suggesting post-transcriptional regulation of CXCR4 differs between control and pathogenic T cells. We further noted CXCR4 was expressed more highly on a per cell basis on BM-infiltrating CD8 + T cells, compared to CD4 + T cells (Fig. 1E ).
Inhibiting CXCR4 in AA mice reduces T cell homing to the BM
The natural ligand for CXCR4, SDF-1α, is present in the BM at high concentrations. 53 We hypothesized that sustained CXCR4 expression on activated T cells might aid in their trafficking to the BM in diseased animals. Therefore, we asked whether reducing CXCR4 expression or preventing SDF-1α-CXCR4 interactions would affect BM-infiltration of T cells in a mouse model of AA.
Cxcr4 knockout mice are embryonic lethal due to defects in B cell lymphopoiesis and myelopoiesis, heart and cerebellar development, and vascularization. We next abrogated SDF-1α-CXCR4 binding using the highly-selective CXCR4
antagonist, AMD3100. 57 To prevent SDF-1α-CXCR4 interactions during T cell expansion, AA mice were given AMD3100 (5mg/kg/day) for 10 days, beginning day +7 post-disease induction.
On day +17, we assessed T cell accumulation in the BM and noted a significant, albeit incomplete reduction in BM-infiltrating CD4 + and CD8 + T cells in AA mice treated with 1 1 AMD3100, compared to those treated with vehicle (Fig. 2C) . Therefore, we analyzed the expression of additional chemokine receptors associated with BM trafficking. Compared to irradiated controls, T cells from spleens and BM of AA mice showed modestly increased CXCR7, CX3CR1, CCR5 and CXCR3 (Fig. 2, D and E). Among these, CCR5 showed the greatest relative increase on BM CD4 + T cells, while CXCR4 was the most highly upregulated on CD8 + T cells (Fig. 2, D and E) . Taken together, these data provide evidence that in AA mice, pathogenic CD8 + T cells aberrantly express and utilize CXCR4 to traffic to the BM, although additional chemokine receptors may also contribute to this process.
Inhibiting NF-κB signaling reduces CXCR4 expression and abrogates T cell migration
NF-κB signaling is central to the activation, proliferation, differentiation, and survival of T we detected increased p50 occupancy at both sites in the Cxcr4 promoter in pathogenic CD8 + T cells. We also observed differential binding of c-Rel in naïve and BM-infiltrating CD8 + T cells (Fig. 4B, C) . Collectively, these data reveal NF-κB-binding to the Cxcr4 promoter is increased in BM-infiltrating CD8 + T cells from AA mice. Furthermore, differences in NF-κB occupancy at the regions we investigated suggest NF-κB differentially regulates Cxcr4 in naïve and pathogenic CD8 + T cells.
Inhibiting NF-κB signaling in AA mice reduces CXCR4 expression in T cells and attenuates AA
Blocking NF-κB signaling impairs bone metastasis in experimental breast cancer models by preventing CXCR4 expression. 58 We inhibited NF-κB signaling in AA mice pharmacologically, 1 3 using DHMEQ or Bay11, or by transferring p50 -/-splenocytes, to determine what effect this would have on T cell infiltration to the BM and disease progression overall. AA mice were treated with DHMEQ (30mg/kg/day) or Bay11 (5mg/kg/every other day) beginning one hour after disease induction and continuing 16 days. On day +17 post-disease induction, mice were humanely euthanized to assess disease severity. Inhibiting NF-κB activity in AA mice robustly protected BM cellularity (Fig. 5A, B) , and this protection extended to circulating white and red blood cells (Fig. S1A, B) . BM-infiltrating CD4 + and CD8 + T cells (Fig. 5C ) and circulating IFNγ and TNF (Fig. S1C, D) were negligible in AA mice with impaired NF-κB signaling, compared to vehicle-treated controls.
Moreover, when AA mice received NF-κB inhibitors or p50 -/-splenocytes, a significantly lower percentage of BM CD8 + T cells expressed CXCR4 (Fig. S1E) , and the per cell expression of CXCR4 on BM CD8 + T cells was significantly lower compared to control-treated AA mice (Fig. 5D) . Consistent with the results of the chromatin immunoprecipitation (Fig. 4) , these data support the notion that NF-κB, and more specifically, p50, play an important role in regulating CXCR4 expression in pathogenic CD8 + T cells.
Finally, we evaluated the survival benefit of pharmacologically limiting NF-κB signaling in AA mice under clinically relevant conditions. AA mice were treated with Bay11
(5mg/kg/every other day) or vehicle only (DMSO) from days +7 to +17 post-disease induction, at which time treatment was discontinued. Compared to DMSO-treated mice for which the median survival time was 19.5 days (range 18 to 24 days), Bay11 treatment significantly extended survival in AA mice, with four of seven mice fully-rescued from lethal BMF (P < 0.01; Fig. 5 H) . Collectively our data demonstrate that attenuating NF-κB signaling in a mouse model Using inhibitors and genetic approaches, we provide evidence that BM-infiltrating CD4 + and CD8 + T cells from AA mice show high CXCR4 expression, suggesting CXCR4-SDF-1α interaction may be one mechanism pathogenic T cells utilize to traffic to the BM during AA progression.
Chemokine receptors, including CX3CR1 and CCR5, facilitate migration of normal and malignant cells to the BM, while CXCR7 has been identified as an additional receptor for SDF-1α. [66] [67] [68] [69] Data presented here ( Fig. Fig. 2 , D and E) are in concordance with previous reports describing elevated CX3CR1 on peripheral and BM T cells, and increased expression of CX3CR1 and CXCR3 in BM T cells of patients with sAA. 67, 70, 71 Reports also indicate peripheral and BM CD4 + regulatory cells T from patients with sAA have reduced CXCR4 expression, compared to those of healthy controls, with impaired ability to home to the BM and suppress pathogenic T cells. 10 In AA mice, CCR5 expression on BM-infiltrating CD4 + T cells showed the greatest increase, while on BM CD8 + T cells, CXCR4 exhibited the highest relative gain.
Residual BM T cells could be detected in AA mice whose disease was induced with CXCR4 -/-splenocytes, or which were treated with AMD3100, indicating chemokine receptors other than CXCR4 may aid in T cell trafficking to the BM. Indeed, we observed modestly augmented CXCR7, CX3CR1, and CXCR3 on BM T cells and their expression levels remained unchanged when CXCR4 was inhibited (data not shown). Thus, dysregulated expression of chemokine receptors may be a general feature of AA progression in mice and in humans.
In breast cancer cell lines, NF-κB directly regulates Cxcr4 expression, which enhances motility in vitro and in vivo metastasis to the BM in animal models. 47 Consistent with this notion, we observed increased p50 occupancy at two distinct NF-κB binding sites in the Cxcr4 promoter in BM-infiltrating CD8 + T cells. These sites were not similarly bound in naïve CD8 + T cells, suggesting differential NF-κB binding to the Cxcr4 promoter in BM-infiltrating CD8 + T cells contributes to aberrant CXCR4 expression. Inhibitory or genetic approaches that limited NF-κB signaling decreased CXCR4 expression on CD8 + T cells, and this further correlated with their reduced trafficking to the BM. However, compared to approaches that only abrogated CXCR4-SDF-1α interactions in AA mice, limiting NF-κB activity resulted in a more profound reduction in T cell infiltration to the BM and negligible circulating IFNγ and TNF. Finally, inhibiting NF-κB in AA mice under therapeutic conditions prolonged their survival, with greater than 50% of mice fully-rescued from lethal BMF, and underscoring the important role for NF-κB in regulating additional proinflammatory pathways that mediate BMF in mice.
Herein we provide evidence that NF-κB-regulated, aberrant CXCR4 expression may be one means by which CD8 + T cells infiltrate the BM during AA progression in mice. The AA 1 6 mice used in this study represent an additional tool with which to better understand a rare and complex BMF disorder; however, as with all animal models, care must be taken when extrapolating results to the human disease. Further studies of paired samples of peripheral blood and BM from patients with AA will be needed to confirm the relevance of our findings.
Determining the full array of chemokine receptors and adhesion molecules that endow pathogenic CD4 + and CD8 + T cells with an ability to traffic to the BM during AA will undoubtedly add to our understanding of the molecular mechanisms that drive this disease.
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